Researchers at Denali Therapeutics have successfully demonstrated a method to transport large therapeutic enzymes across the blood-brain barrier using an engineered antibody fragment. The platform, known as the Transport Vehicle,…
Researchers have identified a potent compound produced by deep-sea Pseudonocardia bacteria that effectively inhibits bone resorption. This marine-derived molecule, Reveromycin A, is being adapted by hospital research teams to treat…
Researchers have identified a potent anti-cancer compound, Salinosporamide A, derived from the deep-sea bacterium Salinispora tropica. Clinical trials at major medical centers are currently evaluating its efficacy in treating glioblastoma,…
A research team based at a Norwegian university hospital has discovered a powerful anti-inflammatory molecule within the deep-sea sponge Geodia barretti. The compound effectively inhibits cytokine production in human cells,…
Vertex Pharmaceuticals has successfully completed Phase 3 trials for suzetrigine, a novel non-opioid pain medication. By targeting specific sodium channels in the peripheral nervous system, the drug blocks pain signals…
